US Tariffs On China Goods Also Target Diagnostics; Industry Preps For USTR Hearing

As more is learned about China-made medtech products facing a potential 25% US tariff, AdvaMed says some diagnostics would also take a hit and is working with its members to prepare for the upcoming US Trade Representative's public hearing on the impacts.